Chronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice

American Journal of Pathology

Volumn 180, Issue 1, 2012, Pages 410-418

  Choi, Soo Kyoung ^a   Galán, Maria ^a   Partyka, Megan ^a   Trebak, Mohamed ^b   Belmadani, Souad ^c   Matrougui, Khalid ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GLUCOSE; INSULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CAPILLARY DENSITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIMB ISCHEMIA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BODY WEIGHT; CAPILLARIES; CYCLIC GMP; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HINDLIMB; INSULIN; ISCHEMIA; MALE; MICE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 83455172701     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.09.016     Document Type: Article

References (42)

1. C.M. Akbari, F.W. LoGerfo Diabetes and peripheral vascular disease J Vasc Surg 30 1999 373 384 (Pubitemid 29395412)
2. S.H. Saydah, J. Fradkin, C.C. Cowie Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 291 2004 335 342 (Pubitemid 38101606)
3. F. Entabi, H. Albadawi, D.H. Stone, R. Sroufe, M.F. Conrad, M.T. Watkins Hind limb ischemia-reperfusion in the leptin receptor deficient (db/db) mouse J Surg Res 139 2007 97 105 (Pubitemid 46482563)
4. D.M. Nathan Long-term complications of diabetes mellitus N Engl J Med 328 1993 1676 1685 (Pubitemid 23157351)
5. A. Rivard, M. Silver, D. Chen, M. Kearney, M. Magner, B. Annex, K. Peters, J.M. Isner Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF Am J Pathol 154 1999 355 363 (Pubitemid 29094086)
6. Amin AH, Abd Elmageed ZY, Nair D, Partyka MI, Kadowitz PJ, Belmadani S, Matrougui K: Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice. Lab Invest 90:985996
7. S. Belmadani, D.I. Palen, R.A. Gonzalez-Villalobos, H.A. Boulares, K. Matrougui Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice Diabetes 57 2008 1629 1637
8. Matrougui K: Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase. Diabetes Metab Res Rev 26:1316
9. A. Senthilkumar, R.D. Smith, J. Khitha, N. Arora, S. Veerareddy, W. Langston, J.H. Chidlow, S.C. Barlow, X. Teng, R.P. Patel, D.J. Lefer, C.G. Kevil Sildenafil promotes ischemia-induced angiogenesis through a PKG-dependent pathway Arterioscler Thromb Vasc Biol 27 2007 1947 1954 (Pubitemid 47312303)
10. R.A. Gonzalez-Villalobos, R. Satou, D.M. Seth, L.C. Semprun-Prieto, A. Katsurada, H. Kobori, L.G. Navar Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension Hypertension 53 2009 351 355
11. J. Jacobi, B.Y.Y. Tam, G. Wu, J. Hoffman, J.P. Cooke, C.J. Kuo Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hind limb ischemia Circulation 110 2004 2424 2429 (Pubitemid 39407349)
12. J.H. Crawford, B.K. Chacko, H.M. Pruitt, B. Piknova, N. Hogg, R.P. Patel Transduction of NO-bioactivity by the red blood cell in sepsis: novel mechanisms of vasodilation during acute inflammatory disease Blood 104 2004 1375 1382 (Pubitemid 39166514)
13. S. Belmadani, K. Matrougui, C. Kolz, Y.F. Pung, D. Palen, D.J. Prockop, W.M. Chilian Amplification of coronary arteriogenic capacity of multipotent stromal cells by epidermal growth factor Arterioscler Thromb Vasc Biol 29 2009 802 808
14. J.P. Cooke NO and angiogenesis Atheroscler Suppl 4 2003 53 60 (Pubitemid 38234495)
15. G. Bernardini, D. Ribatti, G. Spinetti, L. Morbidelli, M. Ziche, A. Santoni, M.C. Capogrossi, M. Napolitano Analysis of the role of chemokines in angiogenesis J Immunol Methods 273 2003 83 101 (Pubitemid 36078465)
16. L. Morbidelli, S. Donnini, M. Ziche Role of nitric oxide in the modulation of angiogenesis Curr Pharm Des 9 2003 521 530 (Pubitemid 36221720)
17. A. De Luca, A. Carotenuto, A. Rachiglio, M. Gallo, M.R. Maiello, D. Aldinucci, A. Pinto, N. Normanno The role of the EGFR signaling in tumor microenvironment J Cell Physiol 214 2008 559 567 (Pubitemid 351224199)
18. H. Greulich, T.H. Chen, W. Feng, P.A. Janne, J.V. Alvarez, M. Zappaterra, S.E. Bulmer, D.A. Frank, W.C. Hahn, W.R. Sellers, M. Meyerson Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants PLoS Med 2 2005 e313
19. J.C. Lee, I. Vivanco, R. Beroukhim, J.H. Huang, W.L. Feng, R.M. DeBiasi, K. Yoshimoto, J.C. King, P. Nghiemphu, Y. Yuza, Q. Xu, H. Greulich, R.K. Thomas, J.G. Paez, T.C. Peck, D.J. Linhart, K.A. Glatt, G. Getz, R. Onofrio, L. Ziaugra, R.L. Levine, S. Gabriel, T. Kawaguchi, K. O'Neill, H. Khan, L.M. Liau, S.F. Nelson, P.N. Rao, P. Mischel, R.O. Pieper, T. Cloughesy, D.J. Leahy, W.R. Sellers, C.L. Sawyers, M. Meyerson, I.K. Mellinghoff Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain PLoS Med 3 2006 e485
20. D. Senador, K. Kanakamedala, M.C. Irigoyen, M. Morris, K.M. Elased Cardiovascular and autonomic phenotype of db/db diabetic mice Exp Physiol 94 2009 648 658
21. J.-X. Chen, A. Stinnett Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice Arterioscler Thromb Vasc Biol 28 2008 1606 1613
22. D. Chalothorn, S.M. Moore, H. Zhang, S.W. Sunnarborg, D.C. Lee, J.E. Faber Heparin-binding epidermal growth factor-like growth factor, collateral vessel development, and angiogenesis in skeletal muscle ischemia Arterioscler Thromb Vasc Biol 25 2005 1884 1890 (Pubitemid 41243458)
23. D. Fukumura, T. Gohongi, A. Kadambi, Y. Izumi, J. Ang, C.O. Yun, D.G. Buerk, P.L. Huang, R.K. Jain Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability Proc Natl Acad Sci USA 98 2001 2604 2609 (Pubitemid 32209529)
24. D.I. Palen, K. Matrougui Role of elevated EGFR phosphorylation in the induction of structural remodelling and altered mechanical properties of resistance artery from type 2 diabetic mice Diabetes Metab Res Rev 24 2008 651 656
25. J.M. Isner, T. Asahara Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization J Clin Invest 103 1999 1231 1236 (Pubitemid 29218292)
26. J.O. Lundberg, E. Weitzberg NO generation from nitrite and its role in vascular control Arterioscler Thromb Vasc Biol 25 2005 915 922 (Pubitemid 40627834)
27. M.T. Eginton, B.W. Mays, H. Kelley, C.D. Hower, M. Dassow, R.A. Cambria, J.B. Towne, G.R. Seabrook, J.A. Freischlag cGMP is decreased after acute ischemia in chronically ischemic canine limbs J Surg Res 86 1999 167 170 (Pubitemid 29517170)
28. R. Zhang, L. Wang, L. Zhang, J. Chen, Z. Zhu, Z. Zhang, M. Chopp Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat Circ Res 92 2003 308 313 (Pubitemid 36258553)
29. G. von Degenfeld, A. Banfi, M.L. Springer, R.A. Wagner, J. Jacobi, C.R. Ozawa, M.J. Merchant, J.P. Cooke, H.M. Blau Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia FASEB J 20 2006 2657 2659
30. Y. Li, S. Hazarika, D. Xie, A.M. Pippen, C.D. Kontos, B.H. Annex In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hind limb ischemia Diabetes 56 2007 656 665 (Pubitemid 46348460)
31. F.C. Sasso, D. Torella, O. Carbonara, G.M. Ellison, M. Torella, M. Scardone, C. Marra, R. Nasti, R. Marfella, D. Cozzolino, C. Indolfi, M. Cotrufo, R. Torella, T. Salvatore Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease J Am Coll Cardiol 46 2005 827 834 (Pubitemid 41224806)
32. S. Hazarika, A.O. Dokun, Y. Li, A.S. Popel, C.D. Kontos, B.H. Annex Impaired angiogenesis after hind limb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1 Circ Res 101 2007 948 956 (Pubitemid 350287182)
33. A.H. Amin, Z.Y. Abd Elmageed, D. Nair, M.I. Partyka, P.J. Kadowitz, S. Belmadani, K. Matrougui Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice Lab Invest 90 2010 985 996
34. Zhao J, Wang W, Ha CH, Kim JY, Wong C, Redmond EM, Hamik A, Jain MK, Feng G-S, Jin ZG: Endothelial grb2-associated binder 1 is crucial for postnatal angiogenesis. Arterioscler Thromb Vasc Biol 31:10161023
35. D.I. Palen, S. Belmadani, P.A. Lucchesi, K. Matrougui Role of SHP-1 Kv 12, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells Cardiovasc Res 68 2005 268 277 (Pubitemid 41428423)
36. M.K. Jones, K. Tsugawa, A.S. Tarnawski, D. Baatar Dual actions of nitric oxide on angiogenesis: possible roles of PKC ERK, and AP-1 Biochem Biophys Res Commun 318 2004 520 528 (Pubitemid 38553811)
37. T. Nishinaka, C. Yabe-Nishimura EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress Free Radic Biol Med 31 2001 205 216 (Pubitemid 32607587)
38. A.K. Desai, V.K. Joshi, C.B. Rao Cyclic neutropenia in a cleft lip and palate patient a case report K G Cleft Palate Craniofac J 2011 Feb 10 [Epub ahead of print]
39. U. Laufs, J.K. Liao Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase J Biol Chem 273 1998 24266 24271 (Pubitemid 28435775)
40. U. Laufs, V. La Fata, J. Plutzky, J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135 (Pubitemid 28152885)
41. M. Yoshizumi, M.A. Perrella, J.C. Burnett Jr, M.E. Lee Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life Circ Res 73 1993 205 209 (Pubitemid 23173071)
42. J. Alonso, L. Sanchez de Miguel, M. Monton, S. Casado, A. Lopez-Farre Endothelial cytosolic proteins bind to the 3′ untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha Mol Cell Biol 17 1997 5719 5726 (Pubitemid 27411079)